Effect of Kabasura Kudineer Extract on Inhibitory Kappa B Kinase Beta and m TOR mRNA Complex Expression in Lung Cancer Cells (A549 Cell)
S. P. Ashwin, S. Preetha, J. Selvaraj, G. Sridevi
Journal of Pharmaceutical Research International · pp. 391–398 · Published 28 Dec 2021
10.9734/jpri/2021/v33i61A35675Abstract
Background: Lung cancer has the highest mortality rate and highest rate of metastasis. Kabasura kudineer was used widely during the Covid period. The aim of the study is to find the effect of kabasura kudineer extract on inhibitory kappa B kinase beta and mTOR mRNA complex expression in lung cancer cells. Materials and Methods: Cell viability test was done using MTT assay. mRNA expression of inhibitory kappa B Kinase and mTOR was done by real-time PCR. The data was analysed statistically by one way analysis of variance and Duncan multiple range test with graph prism version 5. p<0.05 was considered significant. Results: Kabasura kudineer caused a marked increase in cell death in dose dependent manner. At the end of 48 hours, maximum inhibition was at 300 and 400 µg/ml. Kabasura kudineer has inhibited the mRNA expression of inhibitory kappa B Kinase and mTOR in lung cancer cell lines (A549 cell). Conclusion: The study indicates that kabasura kudineer extract has anti cancer activity on the lung cancer cell line (A549 cell).
Cited by 0
No indexed citations yet.
Related research
- Anti-Aging Effects of Ketanserin; Ketanserin Extends Lifespan in Female Drosophila, Inhibits Cellular Senescence and Promotes Wound Healing In-vitro — shares topic coverage
- Identification of microRNAs Involved in mTOR Nutrient Signaling during Adipocyte Differentiation — shares topic coverage
- Comparative Evaluation on the Expression of Pi3 Kinase - AKT- mTOR Signalling Molecules in Oral Squamous Cell Carcinoma - A Real Time PCR Based Approach — shares topic coverage
- Biomarker: A Potential Novel Therapeutic Target for Early Detection of Lung Cancer — shares topic coverage
- Lung Cancer with COVID-19: Symptom and Imaging Analysis-A Dilemma of Managing Multiple Comorbidities — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.